Canadian radiopharmaceutical developer Draxis Health posted a 4% increase in second-quarter revenues of $9.8 million (U.S.) from $9.4 million in the same period last year.
For the period (end-June 30), the Mississauga, Ontario-based firm also reported an operating profitability of $1.6 million, up 23% compared to results in the second quarter of 2000. Revenues have increased 12% to date, from $17.6 million in 2000 to $19.7 million in 2001, according to Draxis. (All figures are expressed in U.S. dollars.)
By AuntMinnie.com staff writersAugust 13, 2001
Related Reading
Draxis posts mixed Q3 results, November, 8, 2000
Draxis gets Canadian OK for BrachySeed, October 10, 2000
DraxImage gets NRC approval for BrachySeed, September 22, 2000
Draxis signs brachytherapy seed agreement with Cytogen, September 14, 2000
Draxis to emphasize radiopharmaceuticals, July 19, 2000
Copyright © 2001 AuntMinnie.com
